Table 2.
Chemotherapy regimen.
Bevacizumab n = 32 |
Chemotherapy n = 32 |
|
---|---|---|
Paclitaxel | 19 (59%) | 5 (16%) |
Cyclophosphamide | 9 (28%) | 2 (6%) |
Doxorubicin | 3 (10%) | 9 (28%) |
Carboplatin/Gemcitabine | 1 (3%) | 8 (25%) |
Pemetrexed | 1 (3%) | |
Carboplatin | 1 (3%) | |
Carboplatin/Paclitaxel | 1 (3%) | |
Etoposide | 2 (6%) | |
Navelbine | 1 (3%) | |
Topotecan | 2 (6%) |